GARY M. RAUCH - 17 Apr 2025 Form 4 Insider Report for TNF Pharmaceuticals, Inc. (TNFA)

Role
Vice President, Finance
Signature
/s/ Gary Rauch
Issuer symbol
TNFA
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
18 Apr 2025, 16:30:15 UTC
Next filing
06 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNFA Employee Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 17 Apr 2025 Common Stock 75,000 $0.1832 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options are subject to expiration if the employment of the Reporting Person is terminated.